Latest News & Features
Americas
AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza. 31 July 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of a lower court that found a patent owned by Regeneron unenforceable because of the biotech company’s inequitable conduct. 28 July 2017
Americas
The US International Trade Commission has begun an investigation into Fujifilm over certain X-ray breast imaging devices. 28 July 2017
Big Pharma
A European Patent Office Board of Appeal has published its decision that invalidated a patent owned by Bristol-Myers Squibb (BMS) which covered a blockbuster anti-cancer drug. 27 July 2017
Americas
GSK has revealed plans to cut back on research and development (R&D), while Eli Lilly announced a plan to focus its R&D resources on oncology. 27 July 2017
Europe
The technology commercialisation activities of the Defence Science and Technology Laboratory (Dstl), an executive agency of the UK’s Ministry of Defence (MOD), generated £75 million ($97.9 million) in net additional exports between 2002/03 and 2015/16. 26 July 2017
Americas
Clinical-stage biotech company Juno Therapeutics has not taken kindly to another business using its name. 26 July 2017
Big Pharma
Medical research charity LifeArc has agreed to provide a range of technology transfer services to the London School of Hygiene & Tropical Medicine. 25 July 2017
Asia-Pacific
Mitsubishi Tanabe has agreed to acquire NeuroDerm, a clinical stage pharmaceutical company, for $1.1 billion. 25 July 2017
Americas
The Patent Trial and Appeal Board has sided with UCB in an inter partes review brought by Mylan. 24 July 2017